Reproductive Health Effects Comparison

Introduction

Reproductive health effects are a major consideration for users of performance-enhancing compounds, but the evidence is uneven. Steroids have decades of human data, while SARMs have mostly rat data and peptides almost none. Axis suppression is covered in our hormonal recovery comparison.

Male Reproductive Effects

Fertility Impact

Compound	Spermatogenesis	Reversibility	Timeline
Steroids	Severe suppression	Usually	Mean 10.4 months; up to 30 in case reports
SARMs	Suppression in rats	Likely	About 4 months (rats)
GH peptides	Not studied	Unknown	N/A
Healing peptides	Not studied	Unknown	N/A

A 2022 review in Therapeutic Advances in Urology describes a study of 72 current and former steroid users: sperm concentration took a mean of 10.4 months to recover, and longer use meant slower recovery. Case reports describe waits of 24-30 months (Asian Journal of Andrology, 2016).

For SARMs, the review notes S-23 caused azoospermia in rats, with fertility back within 4 months. We found no human semen studies. For peptides the gap is missing data, not proof of safety: as of October 2026, FDA cites nonclinical findings of "detrimental effects on male reproduction" for LL-37.

Testicular Effects

Effect	Steroids	SARMs	Peptides
Testicular atrophy	Common	Possible	Not reported
Leydig cell function	Suppressed	Likely suppressed	Not studied
Recovery time	Months	Unknown	N/A

Female Reproductive Effects

Hormonal Disruption

Effect	Steroids	SARMs	Peptides
Menstrual disruption	Common	Possible	No data
Virilization	Dose-dependent	Not well studied	Not reported
Fertility impact	Subfertility reported	Unknown	Unknown

A 2017 Sports Medicine meta-analysis of 33 steroid studies found only six with female athletes. Those reported menstrual irregularities and clitoromegaly along with subfertility.

Long-term Reproductive Considerations

Males

Concern	Steroids	Peptides
Permanent infertility	Rare but possible	Not studied
TRT dependency	Risk with heavy use	Not reported

Some men need hormonal stimulation or assisted reproduction to recover, according to the 2022 review.

Family Planning

Only steroid recovery timelines exist; peptide users haven't been studied.

Protective Measures

Measure	For Steroid Users	For Peptide Users
HCG during cycle	Studied only with TRT	No data
Fertility monitoring	Semen analysis	No data
Sperm banking	Discussed before TRT	Not studied

The hCG data come from prescription TRT: in 26 men, hCG at 500 IU every other day kept semen parameters stable for a year. The review found no study of the SERM use many lifters describe between cycles.

What we still don't know

We found no study testing whether the SARMs lifters use impair human sperm production, or whether any peptide affects fertility. Other organ systems are compared in the long-term effects overview.